title: Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome.
authors.affiliation: Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Madeleine
authors.initials: M
authors.lastname: Duvic
mesh_terms: D000074323:Alemtuzumab; D000630:Aminopterin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000069286:Bortezomib / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D047630:Depsipeptides / Q000627:therapeutic use; D004167:Diphtheria Toxin / Q000627:therapeutic use; D018450:Disease Progression; D004317:Doxorubicin / Q000031:analogs & derivatives / Q000627:therapeutic use; D004583:Electrons / Q000627:therapeutic use; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods; D015994:Incidence; D007376:Interleukin-2 / Q000627:therapeutic use; D000077269:Lenalidomide; D016399:Lymphoma, T-Cell / Q000628:therapy*; D009182:Mycosis Fungoides / Q000628:therapy*; D015649:Pentostatin / Q000627:therapeutic use; D017893:Photopheresis / Q000379:methods; D011092:Polyethylene Glycols / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D012176:Retinoids / Q000627:therapeutic use; D012751:Sezary Syndrome / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000379:methods; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use; D014481:United States; D000077337:Vorinostat; D000093542:Gemcitabine
chemical_list: C418863:10-propargyl-10-deazaaminopterin; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D047630:Depsipeptides; D004167:Diphtheria Toxin; D006877:Hydroxamic Acids; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; D012176:Retinoids; C506643:liposomal doxorubicin; D003841:Deoxycytidine; C078456:denileukin diftitox; D015649:Pentostatin; D000074323:Alemtuzumab; D011092:Polyethylene Glycols; D013792:Thalidomide; D000077337:Vorinostat; D000069286:Bortezomib; D004317:Doxorubicin; C087123:romidepsin; D000077269:Lenalidomide; D000630:Aminopterin; C549035:mogamulizumab; D000093542:Gemcitabine